- Home
- UNH vs NVS Comparison
UNH vs NVS Comparison
Compare UNH & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNH
- NVS
- Stock Information
- Founded
- UNH 1977
- NVS 1895
- Country
- UNH United States
- NVS Switzerland
- Employees
- UNH N/A
- NVS N/A
- Industry
- UNH Medical Specialities
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- UNH Health Care
- NVS Health Care
- Exchange
- UNH Nasdaq
- NVS Nasdaq
- Market Cap
- UNH 279.9B
- NVS 242.8B
- IPO Year
- UNH 1984
- NVS 1991
- Fundamental
- Price
- UNH $281.08
- NVS $117.68
- Analyst Decision
- UNH Buy
- NVS Hold
- Analyst Count
- UNH 24
- NVS 6
- Target Price
- UNH $424.52
- NVS $123.67
- AVG Volume (30 Days)
- UNH 13.2M
- NVS 2.0M
- Earning Date
- UNH 07-29-2025
- NVS 07-17-2025
- Dividend Yield
- UNH 3.15%
- NVS 2.21%
- EPS Growth
- UNH 44.67
- NVS N/A
- EPS
- UNH 23.82
- NVS 6.85
- Revenue
- UNH $410,057,000,000.00
- NVS $55,186,000,000.00
- Revenue This Year
- UNH $13.42
- NVS $7.22
- Revenue Next Year
- UNH $6.38
- NVS $1.94
- P/E Ratio
- UNH $11.80
- NVS $16.53
- Revenue Growth
- UNH 8.06
- NVS 12.95
- 52 Week Low
- UNH $248.88
- NVS $96.06
- 52 Week High
- UNH $630.73
- NVS $124.83
- Technical
- Relative Strength Index (RSI)
- UNH 37.44
- NVS 48.40
- Support Level
- UNH $278.22
- NVS $113.76
- Resistance Level
- UNH $292.64
- NVS $118.32
- Average True Range (ATR)
- UNH 6.82
- NVS 1.68
- MACD
- UNH -0.68
- NVS -0.51
- Stochastic Oscillator
- UNH 9.51
- NVS 35.41
About UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.